Diabetic microvascular disease (DMiVD) is the most common chronic complication of diabetes mellitus, and early identification and effective intervention can significantly improve patients' quality of life and prognosis. The Diabetes and Microcirculation Professional Committee of Chinese Society of Microcirculation and the Primary Endocrine and Metabolic Diseases Group of the Chinese Society of Endocrinology have convened experts in the field to revise the Expert Consensus on Screening and Prevention of Diabetic Microvascular Diseases for Primary Care (2024), based on the 2021 edition, considering the latest research advances and the specific needs of primary care. This consensus elaborates the screening methods, comprehensive management and prevention strategies for DMiVD (diabetic retinopathy, diabetic kidney disease, distal symmetric polyneuropathy and diabetic cardiomyopathy), clarifies the graded diagnosis and treatment and referral processes, emphasizes the importance of preventing and treating DMiVD, and offers guidance and recommendations for physicians, particularly primary care physicians and general practitioners. The aim is to reduce the incidence, progression, and disability associated with DMiVD, ultimately lowering morbidity and mortality rates.

糖尿病微血管疾病（DMiVD）是糖尿病常见的慢性并发症，早期识别及有效干预可以显著提高患者生活质量，改善预后。中国微循环学会糖尿病与微循环专业委员会和中华医学会内分泌学分会基层内分泌代谢病学组组织领域内专家，以2021年版为基础，结合最新研究进展，特别针对基层临床实际需求，修订《基层糖尿病微血管疾病筛查与防治专家共识（2024）》。该共识详尽阐述了DMiVD（糖尿病视网膜病变、糖尿病肾脏病、远端对称性多发性神经病变和糖尿病心肌病）的筛查方法、综合管理及防治策略，明确分级诊疗及转诊流程，强化防治DMiVD重要性，为广大医师特别是基层医生及全科医生提供指导和建议，降低DMiVD的发生率、恶化率以及致残致死率。